BIOGEN INC. Investment Income, Interest
BIOGEN INC. (BIIB) reported Investment Income, Interest of $37.90 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-04-29
- BIOGEN INC. investment income, interest for the quarter ending 2026-03-31 was $37.90M, a 58.58% increase year-over-year.
- BIOGEN INC. investment income, interest for the quarter ending 2025-12-31 was $37.20M, a 101.08% increase year-over-year.
- BIOGEN INC. investment income, interest for the quarter ending 2025-09-30 was $31.60M, a 172.41% increase year-over-year.
- BIOGEN INC. investment income, interest for the quarter ending 2025-06-30 was $32.30M, a 60.70% increase year-over-year.
- BIOGEN INC. investment income, interest for fiscal 2025 was $125.00M, a 84.91% increase from fiscal 2024.
- BIOGEN INC. investment income, interest for fiscal 2024 was $67.60M, a 75.55% decline from fiscal 2023.
- BIOGEN INC. investment income, interest for fiscal 2023 was $276.50M, a 209.63% increase from fiscal 2022.
- BIOGEN INC. investment income, interest for fiscal 2022 was $89.30M, a 711.82% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-03-31 | $37.90M 10-Q · filed 2026-04-29 | $75.10M derived: sum of 2 quarters · filed 2026-04-29 | $106.70M derived: sum of 3 quarters · filed 2026-04-29 | $139.00M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $37.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $68.80M derived: sum of 2 quarters · filed 2026-02-06 | $101.10M derived: sum of 3 quarters · filed 2026-02-06 | $125.00M 10-K · filed 2026-02-06 |
| 2025-09-30 | $31.60M 10-Q · filed 2025-10-30 | $63.90M derived: sum of 2 quarters · filed 2025-10-30 | $87.80M 10-Q · filed 2025-10-30 | $106.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $32.30M 10-Q · filed 2025-07-31 | $56.20M 10-Q · filed 2025-07-31 | $74.70M derived: sum of 3 quarters · filed 2026-04-29 | $86.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $23.90M 10-Q · filed 2026-04-29 | $42.40M derived: sum of 2 quarters · filed 2026-04-29 | $54.00M derived: sum of 3 quarters · filed 2026-04-29 | $74.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $30.10M derived: sum of 2 quarters · filed 2026-02-06 | $50.20M derived: sum of 3 quarters · filed 2026-02-06 | $67.60M 10-K · filed 2026-02-06 |
| 2024-09-30 | $11.60M 10-Q · filed 2025-10-30 | $31.70M derived: sum of 2 quarters · filed 2025-10-30 | $49.10M 10-Q · filed 2025-10-30 | $72.90M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-06-30 | $20.10M 10-Q · filed 2025-07-31 | $37.50M 10-Q · filed 2025-07-31 | $61.30M derived: sum of 3 quarters · filed 2026-02-06 | $157.20M derived: sum of 4 quarters · filed 2026-02-06 |
| 2024-03-31 | $17.40M 10-Q · filed 2025-05-01 | $41.20M derived: sum of 2 quarters · filed 2026-02-06 | $137.10M derived: sum of 3 quarters · filed 2026-02-06 | $213.00M derived: sum of 4 quarters · filed 2026-02-06 |
| 2023-12-31 | $23.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $119.70M derived: sum of 2 quarters · filed 2026-02-06 | $195.60M derived: sum of 3 quarters · filed 2026-02-06 | $276.50M 10-K · filed 2026-02-06 |
| 2023-09-30 | $95.90M 10-Q · filed 2024-10-30 | $171.80M derived: sum of 2 quarters · filed 2024-10-30 | $252.70M 10-Q · filed 2024-10-30 | $302.60M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $75.90M 10-Q · filed 2024-08-01 | $156.80M 10-Q · filed 2024-08-01 | $206.70M derived: sum of 3 quarters · filed 2025-02-12 | $230.60M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $80.90M 10-Q · filed 2024-04-24 | $130.80M derived: sum of 2 quarters · filed 2025-02-12 | $154.70M derived: sum of 3 quarters · filed 2025-02-12 | $167.30M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $49.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $73.80M derived: sum of 2 quarters · filed 2025-02-12 | $86.40M derived: sum of 3 quarters · filed 2025-02-12 | $89.30M 10-K · filed 2025-02-12 |
| 2022-09-30 | $23.90M 10-Q · filed 2023-11-08 | $36.50M derived: sum of 2 quarters · filed 2023-11-08 | $39.40M 10-Q · filed 2023-11-08 | $42.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $12.60M 10-Q · filed 2023-07-25 | $15.50M 10-Q · filed 2023-07-25 | $18.30M derived: sum of 3 quarters · filed 2024-02-14 | $20.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $2.90M 10-Q · filed 2023-04-25 | $5.70M derived: sum of 2 quarters · filed 2024-02-14 | $8.30M derived: sum of 3 quarters · filed 2024-02-14 | $11.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $5.40M derived: sum of 2 quarters · filed 2024-02-14 | $8.10M derived: sum of 3 quarters · filed 2024-02-14 | $11.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $2.60M 10-Q · filed 2022-10-25 | $5.30M derived: sum of 2 quarters · filed 2022-10-25 | $8.20M 10-Q · filed 2022-10-25 | $12.20M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-06-30 | $2.70M 10-Q · filed 2022-07-20 | $5.60M 10-Q · filed 2022-07-20 | $9.60M derived: sum of 3 quarters · filed 2023-02-15 | $15.60M derived: sum of 4 quarters · filed 2023-02-15 |
| 2021-03-31 | $2.90M 10-Q · filed 2022-05-03 | $6.90M derived: sum of 2 quarters · filed 2023-02-15 | $12.90M derived: sum of 3 quarters · filed 2023-02-15 | $20.50M derived: sum of 4 quarters · filed 2023-02-15 |
| 2020-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $10.00M derived: sum of 2 quarters · filed 2023-02-15 | $17.60M derived: sum of 3 quarters · filed 2023-02-15 | $42.00M 10-K · filed 2023-02-15 |
| 2020-09-30 | $6.00M 10-Q · filed 2021-10-20 | $13.60M derived: sum of 2 quarters · filed 2021-10-20 | $38.00M 10-Q · filed 2021-10-20 | $67.20M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-06-30 | $7.60M 10-Q · filed 2021-07-22 | $32.00M 10-Q · filed 2021-07-22 | $61.20M derived: sum of 3 quarters · filed 2022-02-03 | $91.70M derived: sum of 4 quarters · filed 2022-02-03 |
| 2020-03-31 | $24.40M 10-Q · filed 2021-04-22 | $53.60M derived: sum of 2 quarters · filed 2022-02-03 | $84.10M derived: sum of 3 quarters · filed 2022-02-03 | $113.20M derived: sum of 4 quarters · filed 2022-02-03 |
| 2019-12-31 | $29.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $59.70M derived: sum of 2 quarters · filed 2022-02-03 | $88.80M derived: sum of 3 quarters · filed 2022-02-03 | $120.00M 10-K · filed 2022-02-03 |
| 2019-09-30 | $30.50M 10-Q · filed 2020-10-21 | $59.60M derived: sum of 2 quarters · filed 2020-10-21 | $90.80M 10-Q · filed 2020-10-21 | $121.90M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-06-30 | $29.10M 10-Q · filed 2020-07-22 | $60.30M 10-Q · filed 2020-07-22 | $91.40M derived: sum of 3 quarters · filed 2021-02-03 | $117.40M derived: sum of 4 quarters · filed 2021-02-03 |
| 2019-03-31 | $31.20M 10-Q · filed 2020-04-23 | $62.30M derived: sum of 2 quarters · filed 2021-02-03 | $88.30M derived: sum of 3 quarters · filed 2021-02-03 | $117.00M derived: sum of 4 quarters · filed 2021-02-03 |
| 2018-12-31 | $31.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $57.10M derived: sum of 2 quarters · filed 2021-02-03 | $85.80M derived: sum of 3 quarters · filed 2021-02-03 | $112.50M 10-K · filed 2021-02-03 |
| 2018-09-30 | $26.00M 10-Q · filed 2019-10-22 | $54.70M derived: sum of 2 quarters · filed 2019-10-22 | $81.40M 10-Q · filed 2019-10-22 | $105.70M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-06-30 | $28.70M 10-Q · filed 2019-07-24 | $55.40M 10-Q · filed 2019-07-24 | $79.70M derived: sum of 3 quarters · filed 2020-02-06 | $100.30M derived: sum of 4 quarters · filed 2020-02-06 |
| 2018-03-31 | $26.70M 10-Q · filed 2019-04-24 | $51.00M derived: sum of 2 quarters · filed 2020-02-06 | $71.60M derived: sum of 3 quarters · filed 2020-02-06 | $88.50M derived: sum of 4 quarters · filed 2020-02-06 |
| 2017-12-31 | $24.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $44.90M derived: sum of 2 quarters · filed 2020-02-06 | $61.80M derived: sum of 3 quarters · filed 2020-02-06 | $78.50M 10-K · filed 2020-02-06 |
| 2017-09-30 | $20.60M 10-Q · filed 2018-10-23 | $37.50M derived: sum of 2 quarters · filed 2018-10-23 | $54.20M 10-Q · filed 2018-10-23 | $74.60M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-06-30 | $16.90M 10-Q · filed 2018-07-24 | $33.60M 10-Q · filed 2018-07-24 | $54.00M derived: sum of 3 quarters · filed 2019-02-06 | $70.40M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-03-31 | $16.70M 10-Q · filed 2018-04-24 | $37.10M derived: sum of 2 quarters · filed 2019-02-06 | $53.50M derived: sum of 3 quarters · filed 2019-02-06 | $68.90M derived: sum of 4 quarters · filed 2019-02-06 |
| 2016-12-31 | $20.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $36.80M derived: sum of 2 quarters · filed 2019-02-06 | $52.20M derived: sum of 3 quarters · filed 2019-02-06 | $63.40M 10-K · filed 2019-02-06 |
| 2016-09-30 | $16.40M 10-Q · filed 2017-10-24 | $31.80M derived: sum of 2 quarters · filed 2017-10-24 | $43.00M 10-Q · filed 2017-10-24 | $52.10M derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-06-30 | $15.40M 10-Q · filed 2017-07-25 | $26.60M 10-Q · filed 2017-07-25 | $35.70M derived: sum of 3 quarters · filed 2018-02-01 | $41.10M derived: sum of 4 quarters · filed 2018-02-01 |
| 2016-03-31 | $11.20M 10-Q · filed 2017-04-25 | $20.30M derived: sum of 2 quarters · filed 2018-02-01 | $25.70M derived: sum of 3 quarters · filed 2018-02-01 | $30.00M derived: sum of 4 quarters · filed 2018-02-01 |
| 2015-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $14.50M derived: sum of 2 quarters · filed 2018-02-01 | $18.80M derived: sum of 3 quarters · filed 2018-02-01 | $22.10M 10-K · filed 2018-02-01 |
| 2015-09-30 | $5.40M 10-Q · filed 2016-10-26 | $9.70M derived: sum of 2 quarters · filed 2016-10-26 | $13.00M 10-Q · filed 2016-10-26 | $16.50M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-06-30 | $4.30M 10-Q · filed 2016-07-21 | $7.60M 10-Q · filed 2016-07-21 | $11.10M derived: sum of 3 quarters · filed 2017-02-02 | $14.70M derived: sum of 4 quarters · filed 2017-02-02 |
| 2015-03-31 | $3.30M 10-Q · filed 2016-04-21 | $6.80M derived: sum of 2 quarters · filed 2017-02-02 | $10.40M derived: sum of 3 quarters · filed 2017-02-02 | $12.80M derived: sum of 4 quarters · filed 2017-02-02 |
| 2014-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $7.10M derived: sum of 2 quarters · filed 2017-02-02 | $9.50M derived: sum of 3 quarters · filed 2017-02-02 | $12.20M 10-K · filed 2017-02-02 |
| 2014-09-30 | $3.60M 10-Q · filed 2015-10-21 | $6.00M derived: sum of 2 quarters · filed 2015-10-21 | $8.70M 10-Q · filed 2015-10-21 | $10.20M derived: sum of 4 quarters · filed 2016-02-03 |
| 2014-06-30 | $2.40M 10-Q · filed 2015-07-24 | $5.10M 10-Q · filed 2015-07-24 | $6.60M derived: sum of 3 quarters · filed 2016-02-03 | $8.10M derived: sum of 4 quarters · filed 2016-02-03 |
| 2014-03-31 | $2.70M 10-Q · filed 2015-04-24 | $4.20M derived: sum of 2 quarters · filed 2016-02-03 | $5.70M derived: sum of 3 quarters · filed 2016-02-03 | $6.60M derived: sum of 4 quarters · filed 2016-02-03 |
| 2013-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $3.00M derived: sum of 2 quarters · filed 2016-02-03 | $3.90M derived: sum of 3 quarters · filed 2016-02-03 | $8.20M 10-K · filed 2016-02-03 |
| 2013-09-30 | $1.50M 10-Q · filed 2014-10-22 | $2.40M derived: sum of 2 quarters · filed 2014-10-22 | $6.70M 10-Q · filed 2014-10-22 | $13.60M derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-06-30 | $900.00K 10-Q · filed 2014-07-23 | $5.20M 10-Q · filed 2014-07-23 | $12.10M derived: sum of 3 quarters · filed 2015-02-04 | $18.00M derived: sum of 4 quarters · filed 2015-02-04 |
| 2013-03-31 | $4.30M 10-Q · filed 2014-04-23 | $11.20M derived: sum of 2 quarters · filed 2015-02-04 | $17.10M derived: sum of 3 quarters · filed 2015-02-04 | $27.30M derived: sum of 4 quarters · filed 2015-02-04 |
| 2012-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $12.80M derived: sum of 2 quarters · filed 2015-02-04 | $23.00M derived: sum of 3 quarters · filed 2015-02-04 | $29.50M 10-K · filed 2015-02-04 |
| 2012-09-30 | $5.90M 10-Q · filed 2013-10-28 | $16.10M derived: sum of 2 quarters · filed 2013-10-28 | $22.60M 10-Q · filed 2013-10-28 | $28.50M derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-06-30 | $10.20M 10-Q · filed 2013-07-25 | $16.70M 10-Q · filed 2013-07-25 | $22.60M derived: sum of 3 quarters · filed 2014-02-06 | $27.90M derived: sum of 4 quarters · filed 2014-02-06 |
| 2012-03-31 | $6.50M 10-Q · filed 2013-04-25 | $12.40M derived: sum of 2 quarters · filed 2014-02-06 | $17.70M derived: sum of 3 quarters · filed 2014-02-06 | $22.00M derived: sum of 4 quarters · filed 2014-02-06 |
| 2011-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $11.20M derived: sum of 2 quarters · filed 2014-02-06 | $15.50M derived: sum of 3 quarters · filed 2014-02-06 | $19.20M 10-K · filed 2014-02-06 |
| 2011-09-30 | $5.30M 10-Q · filed 2012-10-25 | $9.60M derived: sum of 2 quarters · filed 2012-10-25 | $13.30M 10-Q · filed 2012-10-25 | $17.00M derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-06-30 | $4.30M 10-Q · filed 2012-07-24 | $8.00M 10-Q · filed 2012-07-24 | $11.70M derived: sum of 3 quarters · filed 2013-02-05 | $14.80M derived: sum of 4 quarters · filed 2013-02-05 |
| 2011-03-31 | $3.70M 10-Q · filed 2012-05-01 | $7.40M derived: sum of 2 quarters · filed 2013-02-05 | $10.50M derived: sum of 3 quarters · filed 2013-02-05 | $17.20M derived: sum of 4 quarters · filed 2013-02-05 |
| 2010-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $6.80M derived: sum of 2 quarters · filed 2013-02-05 | $13.50M derived: sum of 3 quarters · filed 2013-02-05 | $22.30M 10-K · filed 2013-02-05 |
| 2010-09-30 | $3.10M 10-Q · filed 2011-10-28 | $9.80M derived: sum of 2 quarters · filed 2011-10-28 | $18.60M 10-Q · filed 2011-10-28 | $29.40M derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-06-30 | $6.70M 10-Q · filed 2011-07-26 | $15.60M 10-Q · filed 2011-07-26 | $26.30M derived: sum of 3 quarters · filed 2012-02-03 | $37.20M derived: sum of 4 quarters · filed 2012-02-03 |
| 2010-03-31 | $8.90M 10-Q · filed 2011-04-21 | $19.60M derived: sum of 2 quarters · filed 2012-02-03 | $30.50M derived: sum of 3 quarters · filed 2012-02-03 | $42.60M derived: sum of 4 quarters · filed 2012-02-03 |
| 2009-12-31 | $10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $21.60M derived: sum of 2 quarters · filed 2012-02-03 | $33.70M derived: sum of 3 quarters · filed 2012-02-03 | $48.50M 10-K · filed 2012-02-03 |
| 2009-09-30 | $10.90M 10-Q · filed 2010-10-26 | $23.00M derived: sum of 2 quarters · filed 2010-10-26 | $37.80M 10-Q · filed 2010-10-26 | |
| 2009-06-30 | $12.10M 10-Q · filed 2010-07-20 | $26.90M 10-Q · filed 2010-07-20 | ||
| 2008-12-31 | $72.10M 10-K · filed 2011-02-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |